TrialBritish journal of clinical pharmacology2019

Dynamics of circulating vascular endothelial growth factor-A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients.

Cong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.